期刊文献+

STI571诱导Jurkat细胞表达HLA-DR、CD_(25)的实验研究

STI571 induces HLA-DR and CD-25 expression in Jurkat cell line
下载PDF
导出
摘要 目的研究观察STI571(商品名格列卫)诱导Jurkat细胞株表达HLA-DR、CD-25分子的作用。方法不同浓度的STI571分别处理Jurkat细胞24h和48h后,用流式细胞仪检测细胞表达HLA-DR、CD-25的百分率。结果与空白对照相比,STI571在0.2~1.2μmol/L浓度下明显促进Jurkat细胞表达HLA-DR、CD-25分子,且诱导效应与时间相关;STI571处理48h比处理24h有更强的诱导效果。结论STI571可显著提高Jurkat细胞HLA-DR、CD-25分子表达率。 Objective To investigate effects of STI571 on HLA-DR and CD-25 expression in Jurkat cell line. Methods Jurkat cells were collected for FCM scan after having been incubated with series concentration of STI571 for 24 or 48 hours. Results Compared with the control, STI571 significantly enhanced the expression of HLA-DR and CD-25 in Jurkat cells within the concentration from 0.2μmol/L to 1.2 μmol/L The expression levels were higher in Jurkat cells treated for 48 hours than those for 24 hours. Conclusion STI571 can significantly induce the expression of HLA-DR and CD-25 in Jurkat cells.
出处 《浙江医学》 CAS 2006年第10期806-807,共2页 Zhejiang Medical Journal
关键词 STI571 Jurkat细胞株HLA—DR CD-25 STI571 Jurkat cells HLA-DR CD-25
  • 相关文献

参考文献4

二级参考文献40

  • 1Peters PJ, Geuze HJ, Van der HA. A new model for lethal hit delivery by cytotoxic T lymphocytes [J]. Immunol Today,1990,11:28.
  • 2毕爱华.医学免疫学 [M].北京 :人民军医出版社,1996.106-158.
  • 3Mcmichael. Monoclonal antibody in clinical medicine [M]. Academic Press, 1982:24.
  • 4Phillips JH,Lanier LL. Dissection of the lymphokine anti vated killer phenomenon:relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis [J]. J Exp Med, 1986, 164:814.
  • 5Ortaldo JR, Manson A, Overton R. Lymphokine activated killer cells: analysis of progenitors and effectors [J]. J Exp Med, 1986, 164:1193.
  • 6Yacyshyn MB, Poppema S, Berg A, et al. CD69 and HLADR activation antigens on peripheral blood lymphocyte populations in metastatic. breast and ovarian cancer patients: correlations with survival following active specific immunotherapy [J]. Int J Cancer, 1995, 61(4):470- 474.
  • 7Hong WS, Min YI, Son YS, et al. Peripheral blood lymphocyte subsets in patients with stomach cancer [J]. J Korean Med Sci, 1995, 10(3):164- 168.
  • 8Matsushita K, Takenouchi T, Kobayashi S, et al. HLA-DR antigen expression in colorectal carcinomas: Influence of expression by IFN-gamma in situ and its association with tumour progression. Br J Cancer, 1996,73(5):644.
  • 9Zlegler SF, Levin SD, Jelurson L, et al. The mourse CD69gene, structure, expression and mapping to the NK gene complex. J Immunol, 1994,152(3): 1228.
  • 10Yacyshyn MB, Poppema S, Berg A, et al. CD69+ and HLA-DR+ activion antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy. Int J Cancer, 1995,61:470.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部